Navigation Links
Product in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

... about the future, including without limitation, product development, product launches, regulatory approvals, market position, ... of so-called authorized-generic drugs; (7) new product development and launch, including the possibility ...

Novavax Reports Second Quarter 2009 Financial Results

... including the Company's ability to progress any product candidates in preclinical or clinical trials; the ... studies or clinical trials is positive, the product may not prove to be safe and efficacious; ... obtain adequate financing in the future through product licensing, co-promotional arrangements, public or ...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

... associated with the OsseoFit Bone Void Filler product line. Under the terms of the agreement, the ... rights for the OsseoFit Bone Void Filler product line to Kensey Nash, including rights to future ... worldwide rights to the OsseoFit Bone Void Filler product line, as well as future extensions of the ...

NeurogesX Reports Second Quarter 2009 Results

... to advance its acetaminophen and opioid prodrug product candidates. NGX-9674 and NGX-5752, ... diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to ...

AOBO Announces New Product Launch

... Boke Nasal Spray Brand - - Diversifies product Offering with Capsule Formulation - ... announced that the Company has launched a new product for the rhinitis and allergy market, called ... 1.0 billion at present. Jingwei is an excellent product that is both effective and safe. With AOBO's ...

American Oriental Bioengineering Reports Second Quarter 2009 Financial Results

... continued revenue mix shift to CCXA's generic product sales, increasing raw material prices and ... we continued to enhance our diversified product portfolio and pursue further vertical ... extensive distribution platform, diversified product offering and ongoing rural expansion offset ...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

... distributing the MXP System for the Company. The product is a microprocessor-controlled device and has a ... processing technologies and should increase product sales," said J. Melville Engle, Chief Executive ... distribution partner for the AXP cord blood product except for Central and South America, China and ...

Microbix Sales Grow 22% For Nine Months

... in fiscal 2010," Mr. Gastle added. "A new product line is being launched late in 2009 that will ... following six months. We see the growth trend in product volume enjoyed in 2009 continuing into 2010 ... inventory as well as the regulatory file for the product (formerly known as Abbokinase(R), now rebranded ...

ThermoGenesis Provides Update on Fiscal 2009 Results

... with the planned divestiture of the CryoSeal product line. Also included in non-recurring ... Technologies. Relaunch of ThermoLine(TM) product group. Utilizing outsourced manufacturing, the Company expects improved product availability, quality and cost. ...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

... sales of MassARRAY((R)) systems. Cost of product and service revenue for the second quarter of ... consumable sales as a percentage of the company's product mix. Consumables are higher margin products as ... reflected additional expenses associated with product development, as well as expenses associated with ...

Telik Announces Second Quarter 2009 Financial Results

... cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary ... market products that are more effective than its product candidates, or obtain marketing approval before ... will not be permitted to commercialize these product candidates. Detailed information regarding ...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... and breast cancer models for the company's first product candidate, OMP-21M18, underlining the therapeutic ... reporting results from our initial trials as this product advances through the clinic." These data ... pipeline includes several novel preclinical product candidates targeting multiple validated cancer ...

Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments

... of a robust manufacturing process for the product leading to cGMP production for supplying ... a potential future commercial manufacturer of the product using Eden's MHRA-inspected state-of-the-art cGMP ... CEO of Omnio Healer AB, said, "Our protein product has shown very promising preclinical results in ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... of our important Quill(TM) SRS and HemoStream(TM) product lines," said Dr. William Hunter, President and ... - Total revenue was $64.6 million. - Net product sales were $47.2 million. Sales of our ... Products were $13.5 million, or 29% of total product sales. Sales of our Base Medical Products ...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... year 2010 revenue was comprised of Protein A product revenue of $2,473,000 and royalty and other ... ---- ---- Revenue: product revenue $2,472,590 ... 13,660,245 Operating expenses: Cost of product revenue 1,270,474 ...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... limitation, the potential failure of these product candidates to prove safe and effective for ... ---- ---- ---- Revenues: product sales $- $2,870 $- ... ----- Operating expenses, net: Cost of product sold - 767 - ...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

... diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to ... 2009. NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, ...

PDI Reports 2009 Second Quarter Financial Results

... cost reductions Mutual termination of product commercialization contract Appointment of ... field resources. This further expands our product offerings while leveraging our core abilities. ... disclosed, we also mutually terminated our product commercialization contract. "We were also ...

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

... focused on the development of pharmaceutical product candidates for the treatment of obesity. The Company's lead combination product candidates targeted for obesity are Contrave(R), ... stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group ...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... developing and commercializing proprietary product candidates principally for use in the hospital ... (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and ... in early 2009 and submitted an NDA for this product candidate in May 2009. Further, in March 2009, ...

Pharmasset to Present at Canaccord Adams Conference

... We currently have three clinical-stage product candidates: RG7128, a nucleoside analog for ... clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... Q2 2009(1) product sales $558 million -21% product sales (excluding ADDERALL XR) $491 million +20% product sales growth (excluding ADDERALL XR) at ...

Pharmacyclics, Inc. Rights Offering Oversubscribed

... it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is ... and future income in exchange for adding to their product pipelines. Pharmacyclics strives to generate ...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

... not historical facts. These statements include product development, product potential projections and estimates and their ... application that may be filed for any such product candidates as well as their decisions regarding ...

Omeros Appoints New Vice President of Clinical Development

... clinical studies for Omeros' PharmacoSurgery(TM) product candidates. These include OMS103HP, the Company's ... nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary ... clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

... $27.8 million in the second quarter of 2008. product revenue from the Onco type DX(R) breast cancer ... quarter of 2009, approximately 50 percent of product revenue was recorded on an accrual basis and ... expenses were $40.5 million, including cost of product revenues of $7.9 million, in the second quarter ...

Micromet Closes $80.5 Million Public Offering of Common Stock

... cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies ... treatment of melanoma. Micromet's preclinical product pipeline includes several novel BiTE antibodies ... efficacy, safety and intended utilization of our product candidates, the conduct, timing and results of ...

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

... technology to significantly improve an existing product or process. About Oramed Pharmaceuticals ... timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... Enhancers available for use in all packaged food product fields not currently partnered by Senomyx, ... enables up to 50% reduction of sugar in numerous product prototypes while retaining the natural taste, as ... reductions in the bitterness of a variety of product prototypes and food ingredients including tea, ...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

... milestones, the timing and success of Nile's product development, future financial position, future ... need to raise additional capital to fund its product development programs to completion, Nile's reliance on third-party researchers to develop its product candidates, and its lack of experience in ...

Oncothyreon appoints Diana Hausman as Vice President of Clinical Development

... program for the Company's pipeline of oncology product candidates. "Dr. Hausman is an experienced ... strategy for two promising small molecule product candidates, each directed at an exciting target ... to future clinical development plans for our product candidates. These forward-looking statements ...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

... of a series of new, proprietary Quill(TM) SRS product codes specifically designed for laparoscopic, or ... surgical procedures. Angiotech's new Quill SRS product codes for laparoscopic gynecology procedures are ... Self-Retaining System (SRS) The Quill SRS product line represents a revolutionary technology in ...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

... Sweet Enhancers worldwide in virtually all food product categories not currently licensed to other ... "Their strong full-service capabilities include product development, proprietary formulation systems and ... and cooling areas. Senomyx has entered into product discovery and development collaborations with ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

... cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies ... treatment of melanoma. Micromet's preclinical product pipeline includes several novel BiTE antibodies ... efficacy, safety and intended utilization of our product candidates, the conduct, timing and results of ...

NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

... Wu's areas of expertise include product licensing and technology collaborations, strategic business planning, international marketing, new product planning, and international project management. ... to discuss scientific and technical aspects of product registration. Previously Wu was vice ...

Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores

... are supported by intensive banner advertising and product support at the village level that drive awareness ... International, Inc. "Our goal is to get the product into the hands of more and more farmers so they ... this. We are confident that the sales of our product will increase as the farmers have the opportunity ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... to negotiate for the commercialization of the product in Canada and Mexico. Transcept has retained an ... collaboration will also support our continued product pipeline expansion efforts. Finally, our option ... is part of Purdue's plan to diversify our product portfolio and broaden our commercial focus into ...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

... diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza((TM)), a dermal patch designed ... 2009. NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... and chemical weapons. PharmAthene's lead product development programs include: ... from the administration of the Company's product candidates, unexpected funding delays and/or ... validation of manufacturing processes for our product candidates, unexpected determinations that ...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

... ability to enter into collaborations around its product candidates, its ability to successfully develop ... scope and validity of patent protection for its product candidates, regulatory developments involving its product candidates and its ability to obtain additional ...
Other Contents
(Date:8/21/2014)... but they are the ultimate source of all organic ... dependent on algae, too, to suck up climate-warming carbon ... bottom of the ocean. Now, by using a combination ... showing that viruses infecting those algae are driving the ... else stays essentially the same, and this has important ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- LiveScan Service Provider  Binary ... a partnership with Gabriel Health Institute, one of ... Certified Nursing Assistant preparatory schools. The agreement ... member of Binary,s LiveScan service provider,s owner/operator team; ... its service capabilities by widening the service ...
(Date:8/21/2014)... -- Nine researchers from Beth Israel Deaconess ... in "The World,s Most Influential Scientific Minds 2014," ... Thomson Reuters ScienceWatch, a web resource for science metrics ... recognized as among the most influential "are performing and ... the advancement of their science," according to a Thomson ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
(Date:8/22/2014)... 2014 (HealthDay News) -- An intensive effort to sterilize feral ... shelter in Florida and euthanized, a new study reveals. ... slow their intake into animal control," Dr. Julie Levy, a ... of Veterinary Medicine, said in a university news release. ... a big impact," she explained, "so we wanted to pick ...
(Date:8/22/2014)... Renal artery stenting to open blockages in ... historically been excluded from modern clinical trials, according ... in Catheterization and Cardiovascular Interventions today ... (SCAI). , University Hospitals Case Medical Center,s Sahil ... Professor of Medicine, Case Western Reserve University School ...
(Date:8/22/2014)... 2014 (HealthDay News) -- Counseling may do little to ... finds. Researchers analyzed 66 studies that included nearly ... at high risk for drinking problems. Participants in 49 ... in the rest of the studies attended group sessions ... A counseling technique called motivational interviewing was used in ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 A new, ... mood-food connection. The summit is no-cost and open to ... best kept secrets, practical tips and advice on how to ... lose or manage weight. Mindful eating is not a ... and stay motivated instead of an "eat this, don't eat ...
Breaking Medicine News(10 mins):Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
Other TagsOther Tags